Business

Voisin Consulting to Advance Pharmacovigilance Capabilities with Oracle

Voisin Consulting Life Sciences (VCLS), a well-established contract research organization (CRO) with a focus on unmet medical need and rare drug clinical trials, has chosen Oracle Argus to significantly enhance its global pharmacovigilance operations. By choosing Argus, VCLS will gain proven tools to enhance and deliver comprehensive, end-to-end pharmacovigilance services to its diverse global clientele.

articleOracle CorporationJanuary 26, 20263/company/oracle-corporation/news/voisin-consulting-to-advance-pharmacovigilance-capabilities-with-oracle
Voisin Consulting to Advance Pharmacovigilance Capabilities with Oracle

About this update from Oracle Corporation

[{"type":"text","content":"Oracle's leading safety platform will help Voisin enhance compliance, mitigate risk, and expand global service offerings for its pharmaceutical clients","length":155,"tagName":"p","attribs":{}},{"type":"text","content":"AUSTIN, Texas, Jan. 26, 2026 /PRNewswire/ -- Voisin Consulting Life Sciences (VCLS), a well-established contract research organization (CRO) with a focus on unmet medical need and rare drug clinical trials, has chosen Oracle Argus to significantly enhance its global pharmacovigilance operations. By choosing Argus, VCLS will gain proven tools to enhance and deliver comprehensive, end-to-end pharmacovigilance services to its diverse global clientele.","length":452,"tagName":"p"},{"type":"image","alt":"(PRNewsfoto/Oracle)","displaySize":"","headline":null,"caption":"(PRNewsfoto/Oracle)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":124,"url":"https://media.zenfs.com/en/prnewswire.com/67c05716b5a602f07373eea3f949608e"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/Eg248Uf701cnkfB1E.T0ug--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTIxOTtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/67c05716b5a602f07373eea3f949608e","width":400,"height":124}},"href":"https://mma.prnewswire.com/media/1766551/Oracle_Logo_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":""As a CRO deeply invested in specialized clinical trials, delivering cutting-edge and highly efficient pharmacovigilance services is fundamental to our success and the safety of our clients' patients," said Dr. Emmanuelle Voisin, founder and chief executive officer, VCLS. "Oracle Argus provides the advanced features, configurability, and reporting requirements we need to scale our operations, boost efficiency, and provide superior service to our expanding client roster."","length":504,"tagName":"p"},{"type":"text","content":"VCLS chose Oracle Argus for its comprehensive capabilities, industry leadership, and proven track record. Oracle Argus solution will help VCLS strengthen its safety services and meet complex sponsor requirements to support a wide array of clients.","length":247,"tagName":"p"},{"type":"text","content":""With today's complex regulations, CROs need a dependable, advanced safety solution," said Seema Verma, executive vice president and general ...

More updates from Oracle Corporation

Oracle ArgusVoisin Consulting Life SciencesOracle CorporationOracle CloudVCLSEmmanuelle Voisindrug developmentsafety servicesOracle Life SciencesPharmacovigilanceclinical research